22
Views
11
CrossRef citations to date
0
Altmetric
Articles

Comparison of 5-Fluorouracil and 5-Fluoro-2'-Deoxyuridine as an Effector in Radiation-Activated Prodrugs

Pages 390-396 | Published online: 18 Jul 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yuta Shibamoto, Chikao Sugie, Masato Ito & Hiroyuki Ogino. (2004) The Japanese experiences with hypoxia-targeting pharmacoradiotherapy: from hypoxic cell sensitisers to radiation-activated prodrugs. Expert Opinion on Pharmacotherapy 5:12, pages 2459-2467.
Read now

Articles from other publishers (10)

Pooja DuaSajeesh SSoyoun KimDong-ki Lee. (2015) ALPPL2 Aptamer-Mediated Targeted Delivery of 5-Fluoro-2′-Deoxyuridine to Pancreatic Cancer. Nucleic Acid Therapeutics 25:4, pages 180-187.
Crossref
A. Miyakawa, Y. Shibamoto, S. Otsuka & H. Iwata. (2013) Applicability of the linear-quadratic model to single and fractionated radiotherapy schedules: an experimental study. Journal of Radiation Research 55:3, pages 451-454.
Crossref
Takeo Ito, Kazuhito Tanabe, Hisatsugu Yamada, Hiroshi Hatta & Sei-ichi Nishimoto. (2008) Radiation- and Photo-induced Activation of 5-Fluorouracil Prodrugs as a Strategy for the Selective Treatment of Solid Tumors. Molecules 13:10, pages 2370-2384.
Crossref
Alvaro A.A. de Queiroz, Gustavo A. Abraham & Olga Zazuco Higa. (2006) Controlled release of 5-fluorouridine from radiation-crosslinked poly(ethylene-co-vinyl acetate) films. Acta Biomaterialia 2:6, pages 641-650.
Crossref
Kazuhito Tanabe, Yuji Makimura, Yukihiro Tachi, Akemi Imagawa-Sato & Sei-ichi Nishimoto. (2005) Hypoxia-selective activation of 5-fluorodeoxyuridine prodrug possessing indolequinone structure: radiolytic reduction and cytotoxicity characteristics. Bioorganic & Medicinal Chemistry Letters 15:9, pages 2321-2324.
Crossref
Zhouen Zhang, Hiroshi Hatta, Kazuhito Tanabe & Sei-ichi Nishimot o. (2005) A New Class of 5-Fluoro-2?-deoxyuridine Prodrugs Conjugated with a Tumor-Homing Cyclic Peptide CNGRC by Ester Linkers: Synthesis, Reactivity, and Tumor-Cell?Selective Cytotoxicity. Pharmaceutical Research 22:3, pages 381-389.
Crossref
Hiroyuki OGINO, Yuta SHIBAMOTO, Chikao SUGIE & Masato ITO. (2005) Biological Effects of Intermittent Radiation in Cultured Tumor Cells: Influence of Fraction Number and Dose Per Fraction. Journal of Radiation Research 46:4, pages 401-406.
Crossref
Hao Jiang, Jing Lu, Ji Jiang & Pei Hu. (2004) Important Role of the Dihydrouracil/Uracil Ratio in Marked Interpatient Variations of Fluoropyrimidine Pharmacokinetics and Pharmacodynamics. The Journal of Clinical Pharmacology 44:11, pages 1260-1272.
Crossref
Yuta Shibamoto, Yukihiro Tachi, Kazuhito Tanabe, Hiroshi Hatta & Sei-Ichi Nishimoto. (2004) In vitro and in vivo evaluation of novel antitumor prodrugs of 5-fluoro-2′-deoxyuridine activated by hypoxic irradiation. International Journal of Radiation Oncology*Biology*Physics 58:2, pages 397-402.
Crossref
Yuta Shibamoto & Branislav Jeremic. (2004) Biologic premises of combined radiation therapy and chemotherapy in lung cancer. Hematology/Oncology Clinics of North America 18:1, pages 29-40.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.